Clinical trial / 2013
Vaginal vitamin C tablets significantly reduced the 6-month recurrence rate of bacterial vaginosis compared with placebo.
A randomized, double-blind, placebo-controlled trial evaluated vaginal vitamin C tablets (250 mg ascorbic acid) versus placebo taken for 6 consecutive days per month across 6 cycles in 142 women recently cured of bacterial vaginosis. During the first 3 months, recurrence was 6.8% in the vitamin C group compared to 14.7% in the placebo group. Over 6 months, recurrence was significantly lower with vitamin C at 16.2% versus 32.4% with placebo (P = 0.024), effectively halving the recurrence risk.
- Study type
- Randomised, double-blind, placebo-controlled clinical trial
- Who was studied
- 142 women cured from a recent episode of bacterial vaginosis
- What was measured
- Recurrence rate of bacterial vaginosis over 3 and 6 months
THE PAPER
Efficacy of vitamin C vaginal tablets as prophylaxis for recurrent bacterial vaginosis: a randomised, double-blind, placebo-controlled clinical trial.
Krasnopolsky VN, Prilepskaya VN, Polatti F, Zarochentseva NV, Bayramova GR, Caserini M, Palmieri R. J Clin Med Res, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.